t.dumitru

TL2 · Rosario

Contributes reviews on supplier material. Based in Rosario.

Joined 3 October 2024 · last posted 7d

96 posts, newest first. Showing up to 150.

Forced degradation studies: designing one that is informative Replied, post #103 · Analytics › Method validation · 21 Jul 2026 · 1 like On forced degradation studies: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than…
A structured critique template this community uses — a second dataset Replied, post #42 · Evidence › Study critique · 18 Jul 2026 · 11 likes Answering the question post #40 raises rather than the one it answers. The strongest critiques cite the section they rely on. A critique without a page reference is an…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #60 · Analytics › Home & field testing · 7 Jul 2026 · 31 likes Where I part company with post #57, and it is a narrow parting. A home refractometer is not measuring what people hope it is measuring in these preparations, and the…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #58 · Practice › Dosing & titration · 3 Jul 2026 · 12 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Angle of injection and whether 90 degrees is always right — the long version Replied, post #35 · Practice › Administration · 30 Jun 2026 · 5 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #55 · Compounds › Secretagogues & GH axis · 30 Jun 2026 · 23 likes Post #52 and I disagree about the size of the effect, not about the direction. The useful distinction on secretagogues and glucose tolerance is between what was…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #36 · Analytics › Method validation · 28 Jun 2026 · 0 likes Linearity across the working range is a routine demonstration and it constrains how far a result can be extrapolated. A method linear from 80 to 120 per cent of nominal…
Publication patterns in the BPC-157 literature, examined Replied, post #23 · Compounds › Repair & healing peptides · 28 Jun 2026 · 20 likes The bit of publication patterns that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
Manufacturer assistance programmes and their eligibility rules Replied, post #37 · Access › Pricing · 26 Jun 2026 · 14 likes Answering the question post #33 raises rather than the one it answers. The cost of an independent submission is worth stating in these threads, because it is the main…
Revisiting: Theoretical plates: useful number or ritual? Replied, post #12 · Analytics › HPLC & UHPLC · 9 Jun 2026 · 0 likes Post #11 answers the question as asked. The question underneath it is different. The most useful reply I ever got about Theoretical plates was a request to state my…
Racemisation and why it is invisible to a mass measurement Replied, post #23 · Analytics › Impurities & related substances · 9 Jun 2026 · 0 likes Narrowing post #22, because the general version has more than one answer. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear…
An 18-month record including the parts that went badly Replied, post #28 · Outcomes › Progress reports · 30 May 2026 · 27 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series. I have seen it go both ways, which is why I hedge.
Purity assay versus content assay: two different numbers Replied, post #2 · Analytics › COA interpretation · 25 May 2026 · 0 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
Spreadsheets: an appreciation — what changed since Replied, post #51 · Lounge › Off topic · 24 May 2026 · 25 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.…
Alcohol: what is documented and what is folklore Replied, post #18 · Practice › Interactions · 19 May 2026 · 30 likes Taking post #16 at face value and following it one step further. A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription…
Injection volume, overload, and peak distortion Replied, post #9 · Analytics › HPLC & UHPLC · 16 May 2026 · 29 likes Post #7 is right about the mechanism and I think understates the practical bit. Carryover from a previous injection shows up as a small peak at the same retention time…
Tracking intake honestly when appetite is absent Replied, post #21 · Nutrition & Training › Protein & intake · 10 May 2026 · 3 likes Picking up post #20: that is the part I would want checked first. My position on tracking intake is current rather than settled. I have revised it once already and I…
Request: show the solution author in the topic list — what changed since Replied, post #78 · Meta › Feature requests · 4 May 2026 · 1 like Then the honest version is a comparison of the record shapes rather than the scores. How many results, over how long, from which services. That I would use. Anyone with…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #46 · Evidence › Journal club · 2 May 2026 · 22 likes Building on post #43 rather than restating it. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #59 · Sourcing › Vendor reports · 30 Apr 2026 · 12 likes Where you have no independent result, a documentation report is still worth filing: what the certificate contained, what it omitted, and how fast a request was…
Blind submission and why it changes minds — the long version Replied, post #46 · Sourcing › Independent verification · 28 Apr 2026 · 13 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #22 · Devices › Syringes & needles · 23 Apr 2026 · 0 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #19 · Practice › Reconstitution · 21 Apr 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #13 · Practice › Reconstitution · 12 Apr 2026 · 33 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Coming back to: Training through a dose escalation week Replied, post #55 · Nutrition & Training › Resistance training · 18 Mar 2026 · 0 likes The claim about Training through a dose escalation upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #64 · Compounds › Cagrilintide & amylin analogues · 14 Mar 2026 · 0 likes An honest declaration on nausea profile of amylin analogues: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #27 · Compounds › Repair & healing peptides · 10 Mar 2026 · 18 likes Agreed, and I will stop repeating the version of this I had been repeating.
Why the titration planner refuses to produce a schedule below a floor Replied, post #45 · Data & Tools › Calculators · 3 Mar 2026 · 17 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way. I am reporting what…
Measurement error in a self-reported exposure Replied, post #54 · Evidence › Study critique · 24 Feb 2026 · 3 likes Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered is a criticism of the field rather than of the…
The most common factual error about semaglutide on the internet — what changed since Replied, post #34 · Compounds › Semaglutide · 24 Feb 2026 · 2 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
Second pass at: Identical chromatograms across two different lots Replied, post #23 · Sourcing › Red flags · 23 Feb 2026 · 0 likes The arithmetic in post #21 is right; the assumption feeding it is the part to check. Two things can be true about Identical chromatograms at once: the mechanism is…
Revisiting: Absolute versus relative contraindications Replied, post #29 · Safety › Contraindications · 21 Feb 2026 · 8 likes Post #27 describes the usual case. This is about the unusual one. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to…
Blinding yourself: practical methods and their limits Replied, post #6 · Research Methods › N-of-1 designs · 19 Feb 2026 · 24 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #13 · Evidence › Journal club · 30 Jan 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #24 · Practice › Storage & stability · 23 Jan 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I have left out…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #36 · Evidence › Trials · 17 Jan 2026 · 1 like Picking up post #35: that is the part I would want checked first. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #90 · Practice › Side effects · 13 Jan 2026 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Filter needles: when they help and what they cost you Replied, post #18 · Devices › Syringes & needles · 4 Jan 2026 · 2 likes Taking filter needles seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
Tracking that stops updating and then resumes — the long version Replied, post #56 · Sourcing › Logistics · 25 Dec 2025 · 7 likes Where I part company with post #55, and it is a narrow parting. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is…
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #21 · Compounds › Oral incretins · 28 Nov 2025 · 10 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #76 · Practice › Dosing & titration · 17 Nov 2025 · 3 likes Coming back to post #72, because the follow-up matters more than the original answer. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #17 · Practice › Side effects · 4 Nov 2025 · 9 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
IGF-1 as a surrogate endpoint and its limitations Replied, post #3 · Compounds › Secretagogues & GH axis · 3 Nov 2025 · 3 likes The confident answers on IGF-1 and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Payment mechanics and the recovery options that do not exist Replied, post #22 · Sourcing › Payments · 19 Oct 2025 · 0 likes Refund policy before ordering: ask what the policy is if you receive damaged material or if the order is incorrect. Get it in writing or screenshot it.
Sleep tracking data and its considerable limitations Replied, post #13 · Wellbeing › Sleep · 16 Oct 2025 · 22 likes The published data on sleep outcomes in this class is thinner than the volume of discussion, which is worth saying plainly. For what it is worth, the same held on the…
Pinch or no pinch, and how needle length changes the answer Replied, post #108 · Practice › Administration · 13 Oct 2025 · 10 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
Compounds this community declines to help with, and why Replied, post #46 · Compounds › Other compounds · 2 Oct 2025 · 0 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
About the European Union category Replied, post #6 · Regional › European Union · 25 Sep 2025 · 18 likes Everything in post #2 holds. The case it does not cover is the one I have. Regional stock held inside the union removes a customs question entirely for intra-union…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #90 · Practice › Side effects · 24 Sep 2025 · 0 likes Adding the measurement that post #89 says would settle it. I think the nausea timeline question is answerable and has not been answered, which is a more optimistic…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #9 · Analytics › HPLC & UHPLC · 23 Sep 2025 · 22 likes Post #7 is right about the mechanism and I think understates the practical bit. A chromatogram image at a resolution where you can see peak shape but not baseline…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #81 · Evidence › Study critique · 15 Sep 2025 · 13 likes My understanding of Reverse causation is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #64 · Evidence › Study critique · 14 Sep 2025 · 1 like If someone has run Reverse causation properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Titles that describe the question, not the situation — what changed since Replied, post #4 · Start Here › How to Ask · 9 Sep 2025 · 33 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #7 · Data & Tools › Datasets · 6 Sep 2025 · 3 likes Aggregating first-hand accounts does not produce evidence of the kind a trial produces. It produces a description of who chose to post, which is a real thing and a…
Column chemistry choices for a 40-residue peptide Replied, post #28 · Analytics › HPLC & UHPLC · 4 Sep 2025 · 7 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #50 · Sourcing › Vendor reports · 3 Sep 2025 · 23 likes My position on vendor documentation pages is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
A parcel that arrived warm: a decision process, not a verdict Replied, post #6 · Practice › Storage & stability · 19 Aug 2025 · 5 likes Adding the measurement that post #4 says would settle it. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to…
Specification in the result column: why that is a meaningful error Replied, post #30 · Analytics › COA interpretation · 12 Aug 2025 · 5 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
How to research a compound with no human data without deceiving yourself Replied, post #102 · Compounds › Other compounds · 4 Aug 2025 · 1 like Post #99 is the version of this I will quote in future. One addition. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2025 · 2 likes This is the sort of exchange that makes the archive worth searching.
Coming back to: Sample size calculations, read backwards from the published number Replied, post #58 · Evidence › Trials · 18 Jul 2025 · 0 likes Picking up post #55: that is the part I would want checked first. Discontinuation handling is the methodological detail that most changes a result and gets the least…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #56 · Compounds › Repair & healing peptides · 2 Jul 2025 · 25 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
Journal club: SURMOUNT-1, read without the press release Replied, post #147 · Evidence › Journal club · 28 Jun 2025 · 15 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Follow-up: Tracking intake honestly when appetite is absent Replied, post #27 · Nutrition & Training › Protein & intake · 6 Jun 2025 · 0 likes Worth separating two things that post #25 runs together. Marking my uncertainty on Tracking intake explicitly. I am confident about the direction, much less confident…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #18 · Sourcing › Regulatory · 4 Jun 2025 · 0 likes Compound being unapproved was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Individual participant data versus aggregate data Replied, post #31 · Evidence › Meta-analyses · 15 May 2025 · 20 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #26 · Compounds › Oral incretins · 2 May 2025 · 0 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #22 · Sourcing › Independent verification · 18 Apr 2025 · 20 likes Sensible. I would want the same detail before I acted on it either.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #51 · Clinical › Comorbidities · 6 Apr 2025 · 0 likes Worth separating two things that post #47 runs together. I would put moderate confidence on the mainstream reading of obstructive sleep apnoea and no more. That is not…
Why cagrilintide alone is discussed so much less than in combination Replied, post #50 · Compounds › Cagrilintide & amylin analogues · 28 Mar 2025 · 32 likes The interest in combining it with semaglutide is that two different satiety mechanisms might add. Whether they do, and by how much, is exactly what the combination…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #112 · Pharmacology › Receptor biology · 17 Mar 2025 · 0 likes An observation about biased agonism that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
What a seizure notice actually says Replied, post #41 · Sourcing › Logistics · 11 Mar 2025 · 24 likes Source for the seizure notice figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
Certificates issued by the seller versus by a laboratory Replied, post #3 · Analytics › COA interpretation · 11 Mar 2025 · 2 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Follow-up: Requesting a page: what makes a good request Replied, post #7 · Documentation › Wiki requests · 5 Mar 2025 · 4 likes Post #6 is the version of this I will quote in future. One addition. Request a new maintained page: if a question recurs, has a good marked solution, and contains a…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #125 · Sourcing › Regulatory · 5 Mar 2025 · 23 likes A compound in a compounding pathway in one country and unavailable in another is a common situation and produces most of the confusion here. None of the above is…
Consistent declarations and why they matter more than clever ones Replied, post #122 · Sourcing › Logistics · 4 Mar 2025 · 0 likes Post #119 and I disagree about the size of the effect, not about the direction. Import restrictions by jurisdiction: what is legal to import for personal use varies…
A supplier that answers analytical questions with restated claims Replied, post #16 · Sourcing › Red flags · 28 Jan 2025 · 24 likes Post #15 is the version of this I will quote in future. One addition. Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact…
Distinguishing a deletion sequence by mass alone Replied, post #20 · Analytics › Mass spectrometry · 26 Jan 2025 · 0 likes Post #16 and I disagree about the size of the effect, not about the direction. Taking distinguishing a deletion sequence seriously for a moment rather than deflecting:…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 13 Jan 2025 · 0 likes Where the cagrisema phase 2 paper reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #133 · Compounds › Tirzepatide · 6 Jan 2025 · 13 likes Right — I had this wrong and I am glad to have read it before it mattered.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #19 · Compounds › Semaglutide · 19 Dec 2024 · 0 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
SURPASS-2 and the comparator dose question that will not go away Replied, post #71 · Compounds › Tirzepatide · 4 Dec 2024 · 23 likes Picking up post #68: that is the part I would want checked first. Two sentences on SURPASS-2 and then I will stop, because the rest is speculation and the thread is…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #160 · Compounds › Repair & healing peptides · 27 Nov 2024 · 9 likes Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #48 · Wellbeing › Mental health · 24 Oct 2024 · 24 likes Careful with the language on Food noise. "Not detected" and "not present" are different findings and the first is a statement about the method.
Transporting a vial for a weekend away Replied, post #5 · Practice › Storage & stability · 24 Oct 2024 · 1 like That is a fair summary of where the discussion has got to.
Journal club: STEP 4 and what a withdrawal design can prove — one year on Started this topic · Evidence › Journal club · 13 Oct 2024 · 11 likes Journal club: STEP 4 and what a withdrawal design can prove — one year on Writing it up because I had to work it out twice and would rather nobody else did. Session…
Requesting a page: what makes a good request — what changed since Replied, post #67 · Documentation › Wiki requests · 11 Oct 2024 · 14 likes The commonest reason a good request stalls is that nobody converted it into a draft. A rough draft attracts editors; a request does not.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #18 · Access › Shortages · 9 Oct 2024 · 3 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #29 · Compounds › Other compounds · 3 Oct 2024 · 2 likes Nothing to add on the substance. Thank you for taking the question at face value.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #27 · Clinical › Bloodwork · 13 Sep 2024 · 9 likes Bring a laboratory is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #19 · Clinical › Special populations · 6 Sep 2024 · 32 likes Fair, and the limits you put on it are the part I will remember.
Correlation in a self-tracked dataset: what it can support Replied, post #84 · Research Methods › Statistics · 23 Aug 2024 · 13 likes Adding the boring version of correlation, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
MHRA statements, read directly — the long version Replied, post #2 · Regional › UK & Ireland · 21 Aug 2024 · 31 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #9 · Sourcing › Independent verification · 21 Aug 2024 · 0 likes Understood, and I withdraw the assumption I opened with.
How this community labels and discusses unrefereed work Replied, post #86 · Evidence › Preprints · 15 Jul 2024 · 8 likes Community labels: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Assessing a warm arrival: the decision process — one year on Replied, post #70 · Sourcing › Logistics · 31 May 2024 · 23 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…